Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

AI could help emergency physicians triage patients with chest pain
An artificial intelligence (AI) model could help emergency department doctor...Read more on AuntMinnie.comRelated Reading: AI could boost x-ray's performance for diagnosing aortic dissection Chest x-ray tool visualizes COVID-19 pneumonia AI chest x-ray algorithm shows promise for emergency department reads AI improves lung nodule detection in health screening AI chest x-ray software looks promising for use in children (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 18, 2023 Category: Radiology Source Type: news

Ferrum Health adds $6M to coffers
Artificial intelligence (AI) software developer Ferrum Health has raised $6 millio...Read more on AuntMinnie.comRelated Reading: Strategic Radiology, Ferrum Health partner Therapixel, Ferrum Health team up on breast cancer C-MIMI: AI peer review can spot missed lung cancer Ferrum deploys AI platform for lung cancer detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2023 Category: Radiology Source Type: news

Operating in darkness: From Frist's table back to the front lines
This is the last in a three-part series detailing the journey of a group of Ukrainian doctors attempting to launch an organ transplant program at their hospital in Kiev during the middle of the war with Russia. Back in Kiev, the leader of the Ukrainian transplant program says the group is ready to make their first lung transplant. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 13, 2023 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

There May Be a Better Way to Allocate Precious Donor Lungs for Transplant
MONDAY, Jan. 9, 2023 -- A new way of allocating donor lungs that eliminates geographical restrictions could save more lives, new research suggests. In early 2023, the current U.S. system, which looks for compatible candidates within a fixed radius,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2023 Category: General Medicine Source Type: news

AI could boost x-ray's performance for diagnosing aortic dissection
An artificial intelligence (AI) algorithm could boost the performance of x-ra...Read more on AuntMinnie.comRelated Reading: AI chest x-ray algorithm shows promise for emergency department reads AI improves lung nodule detection in health screening AI may aid fracture detection in osteoporotic patients AI model predicts heart disease risk from x-rays New study questions reliability of bone age AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 22, 2022 Category: Radiology Source Type: news

Science ’s 2022 Breakthrough of the Year: A telescope’s golden eye sees the universe anew
html { scroll-behavior: smooth; } .news-article-content--featured>.bodySection>.mb-2x:not(:first-of-type) { display: none; } h3 { scroll-margin-top: 5rem; } .parent-section h3, .subsection h3 { font-size: 1.375rem; line-height: 1.875rem; } .news-article-content-footer h2 { display: none; } .toc img { padding-bottom: 16px; transition: opacity .25s; } .toc img:hover { opacity: 60%; } .toc .image-grid img { padding-bottom: 16px; padding-top: 16px; } .image-grid .news-article__figure__image__wrapper:before, .image-grid .news-article__figure__image__wrapper:after { display: none; } .news-article...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news

Roche announces U.S. collaboration with Pfizer to help patients who test positive for COVID-19 navigate risks, symptoms, testing and treatment options
Testing early for COVID-19 can help determine the proper course of treatment.This collaboration helpspatients access critical resources and locate information about testing, available treatment options, high-risk factors that increase the chance of progressing to severe COVID-19, and ways to seek timely care.The Pilot ® COVID-19 At-Home Test will now include a QR code that directs individuals tocovid19knowmore.com, a Pfizer website, to learn more about testing and treatment options.Basel, 14 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has entered into a U.S. focused collaboration with Pfizer to d...
Source: Roche Media News - December 14, 2022 Category: Pharmaceuticals Source Type: news

AI chest x-ray algorithm shows promise for emergency department reads
An artificial intelligence (AI) algorithm that provided readings on bedsid...Read more on AuntMinnie.comRelated Reading: AI improves lung nodule detection in health screening AI may aid fracture detection in osteoporotic patients Video from RSNA 2022: AI implementation trends How to avoid the AI integration traps AI model predicts heart disease risk from x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 9, 2022 Category: Radiology Source Type: news

Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

'Very frightening' Fit and healthy man, 50, gets double lung transplant following Covid
While most people recover from Covid in a matter of days or weeks, some have had far more dramatic recoveries. (Source: Daily Express - Health)
Source: Daily Express - Health - December 7, 2022 Category: Consumer Health News Source Type: news

Tiny Blood Clots May Be to Blame for Long COVID Symptoms, Some Researchers Say
Blood clotting is a normal, healthy process. It’s what stops the bleeding when you slice your finger in the kitchen, for example. But sometimes, clotting goes awry. Clots that block major blood vessels can lead to potentially fatal issues like strokes or heart attacks. Tiny clots in the body’s small blood vessels can also be dangerous. Autopsies of people who died from COVID-19 have shown that some patients develop these tiny “microclots” in their lungs, potentially contributing to respiratory failure. And now, a growing group of researchers believe microclots may also be to blame, at least in part,...
Source: TIME: Health - December 2, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

RadNet's Aidence enters licensing agreement with Google Health
Aidence, a lung artificial intelligence subsidiary of outpatient diagnosti...Read more on AuntMinnie.comRelated Reading: RadNet secures controlling share of U.K.-based cardiothoracic network ECR: AI could avoid further follow-up for lung nodules RadNet reports revenue increases for Q1 AI market churn continues as Sirona buys AI assets from Nines RadNet broadens AI focus with acquisitions of Aidence, Quantib (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 30, 2022 Category: Radiology Source Type: news

Transplant patients die after drinking infected water from hospital supply
Two lung-transplant patients died after drinking infected water at a new specialist hospital, a coroner has concluded. (Source: HSJ)
Source: HSJ - November 23, 2022 Category: UK Health Source Type: news

Small victories: South Africa is struggling to improve kids ’ health decades after apartheid’s demise
KWAZULU-NATAL, SOUTH AFRICA— By her country’s standards at the time, there was nothing too unusual about how Nosipho Mshengu arrived in the world. She was born on the side of the road on 20 September 1993, as her mother tried to get from Mafakatini, a rural village in South Africa where there was then no health facility, to a Roman Catholic clinic an hour away. The bus she awaited was nowhere in sight when time ran out, and Mshengu made her entry then and there. This story was supported by the Pulitzer Center. A little more than 14 years later, Mshengu was pregnant herself. Her labor story...
Source: ScienceNOW - November 22, 2022 Category: Science Source Type: news